The purpose of this study is to determine the safety and efficacy of an investigational drug in patients with type 2 diabetes mellitus.

Condition	Treatment or Intervention	Phase
Diabetes Mellitus, Type 2		Phase II Phase III

Ages Eligible for Study:  18 Years and above,  Genders Eligible for Study:  Both

Criteria

Inclusion Criteria: Type 2 Diabetes Mellitus

Toll Free Number      1-888-577-8839 

Arizona
      Call for Information, Chandler,  Arizona,  85225,  United States; Recruiting
California
      Call for Information, Sacramento,  California,  95825,  United States; Recruiting
Florida
      Call for Information, Kissimmee,  Florida,  34741,  United States; Recruiting
Indiana
      Call for Information, Indianapolis,  Indiana,  46260,  United States; Recruiting
Kansas
      Call for Information, Wichita,  Kansas,  67207,  United States; Recruiting
      Call for Information, Topeka,  Kansas,  66606,  United States; Recruiting
Minnesota
      Call for Information, Edina,  Minnesota,  55435,  United States; Recruiting
New Jersey
      Call for Information, Toms River,  New Jersey,  08753,  United States; Recruiting
      Call for Information, Berlin,  New Jersey,  08009,  United States; Recruiting
New York
      Call for Information, Endwell,  New York,  13760,  United States; Recruiting
      Call for Information, Rochester,  New York,  14609,  United States; Recruiting
North Carolina
      Call for Information, Wilmington,  North Carolina,  28412,  United States; Recruiting
      Call for Information, Winston Salem,  North Carolina,  27103,  United States; Recruiting
      Call for Information, Charlotte,  North Carolina,  28209,  United States; Recruiting
      Call for Information, Durham,  North Carolina,  27710,  United States; Recruiting
Oklahoma
      Call for Information, Tulsa,  Oklahoma,  74104,  United States; Recruiting
Pennsylvania
      Call for Information, Reading,  Pennsylvania,  19601,  United States; Recruiting
      Call for Information, Pittsburgh,  Pennsylvania,  15226,  United States; Recruiting
      Call for International Site Information, Horsham,  Pennsylvania,  19044,  United States; Recruiting
South Carolina
      Call for Information, Mt. Pleasant,  South Carolina,  29464,  United States; Recruiting
      Call for Information, Columbia,  South Carolina,  29201,  United States; Recruiting
Texas
      Call for Information, Madisonville,  Texas,  77864,  United States; Recruiting
      Call for Information, San Antonio,  Texas,  78229-4801,  United States; Recruiting
      Call for Information, Dallas,  Texas,  75230,  United States; Recruiting
      Call for Information, Houston,  Texas,  77030,  United States; Recruiting
Virginia
      Call for Information, Richmond,  Virginia,  23294,  United States; Recruiting
Washington
      Call for Information, Renton,  Washington,  98055,  United States; Recruiting
      Call for Information, Olympia,  Washington,  98502,  United States; Recruiting

Study ID Numbers:  A0604T2DPT
Record last reviewed:  October 2004
Record first received:  July 2, 2004
ClinicalTrials.gov Identifier:  NCT00086502
Health Authority: United States: Food and Drug Administration
ClinicalTrials.gov processed this record on 2004-10-27